Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
35
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Horton Amy | VP, Chief Accounting Officer | 118 | $0 | $1.78M | 2021-12-09 |
| SEMEDO ANTHONY B. | Director | 2 | $260.4K | $0 | 2021-11-29 |
| Davis John E | Senior VP, Global Sales | 74 | $176.9K | $1.21M | 2021-11-29 |
| Maney Rochelle L. | VP, Quality | 1 | $0 | $0 | 2021-11-04 |
| Holloway Jean F | VP, General Counsel | 87 | $0 | $1.61M | 2021-08-31 |
| MORGAN HARVEY | Director | 34 | $0 | $325.5K | 2021-08-30 |
| McCall Ronald D | Director | 36 | $0 | $1.58M | 2021-08-25 |
| Maier Dennis B | Vice President, Operations | 28 | $0 | $395.9K | 2021-08-23 |
| Borgstrom Marna P | Director | 5 | $0 | $0 | 2021-06-01 |
| Salveson Jon W | Director | 12 | $119.8K | $0 | 2021-06-01 |
| Burbank Jeffrey H | Director | 5 | $0 | $0 | 2021-06-01 |
| BEVEVINO DANIEL J | Director | 11 | $0 | $0 | 2021-06-01 |
| Bullock James | Director | 7 | $166.3K | $0 | 2021-06-01 |
| ACKERMAN THOMAS F | Director | 11 | $0 | $0 | 2021-06-01 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 143 | $10.3K | $4.95M | 2021-05-05 |
| Mackin James P | President & CEO | 76 | $352.0K | $11.84M | 2021-04-30 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 1 | $0 | $0 | 2021-03-16 |
| Capps Scott B | VP-Clinical Research | 90 | $0 | $1.23M | 2021-03-12 |
| Barthold Franz Peter | VP, Research & Development | 7 | $0 | $0 | 2021-03-08 |
| Simpson Michael S | SVP, Regulatory Affairs and QA | 12 | $0 | $0 | 2021-03-05 |
| Getz Matthew A | VP, Human Resources | 7 | $0 | $0 | 2021-02-23 |
| Bogenschuetz Thomas J | VP, EMEA & General Manager | 8 | $0 | $0 | 2020-05-05 |
| McDermid James M | SVP, CHRO | 13 | $0 | $0 | 2019-03-14 |
| Saurini Sherry M | VP, Quality | 10 | $0 | $0 | 2019-03-14 |
| RONALD C ELKINS | Director | 33 | $0 | $1.24M | 2018-09-05 |
| Matthews William Robert | Senior VP, Operations, Quality | 12 | $0 | $0 | 2018-03-05 |
| Gale David C | VP-Research and Development | 46 | $0 | $395.6K | 2017-11-16 |
| Benson James | Director | 16 | $0 | $337.8K | 2017-10-02 |
| ANDERSON STEVEN G | President, CEO and Chairman | 37 | $0 | $1.93M | 2015-04-09 |
| Anderson Bruce G. | VP, US Sales and Marketing | 55 | $0 | $829.6K | 2015-03-07 |
| FRONK DAVID | VP, Regulatory Affairs | 34 | $0 | $170.7K | 2015-03-07 |
| Lang David P. | VP, Int'l Sales & Marketing | 10 | $0 | $0 | 2015-02-26 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 35 | $0 | $310.6K | 2014-08-15 |
| SEERY GERALD B | Sr. VP, Sales and Marketing | 7 | $0 | $25.9K | 2012-11-30 |
| HEACOX ALBERT E | Sr. VP Research and Devl | 1 | $0 | $0 | 2011-12-31 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Horton Amy | VP, Chief Accounting Officer | G Gift | 2021-12-09 | 2021-12-10 | 1,500 | $18.82 | $28.2K | 85,282 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2021-12-08 | 2021-12-10 | 2,500 | $18.57 | $46.4K | 86,782 | SEC↗ |
| SEMEDO ANTHONY B. | Director | A Award | 2021-11-29 | 2021-11-30 | 4,992 | $17.36 | $86.7K | 4,992 | SEC↗ |
| SEMEDO ANTHONY B. | Director | P Buy | 2021-11-29 | 2021-11-30 | 15,000 | $17.36 | $260.4K | 19,992 | SEC↗ |
| Davis John E | Senior VP, Global Sales | P Buy | 2021-11-29 | 2021-12-01 | 600 | $17.33 | $10.4K | 72,499 | SEC↗ |
| Maney Rochelle L. | VP, Quality | D To issuer | 2021-11-04 | 2021-11-05 | 214 | $21.21 | $4.5K | 14,108 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2021-08-31 | 2021-09-01 | 663 | $26.49 | $17.6K | 86,567 | SEC↗ |
| MORGAN HARVEY | Director | G Gift | 2021-08-30 | 2021-08-31 | 3,645 | — | $0 | 46,342 | SEC↗ |
| MORGAN HARVEY | Director | G Gift | 2021-08-30 | 2021-08-31 | 3,645 | — | $0 | 50,768 | SEC↗ |
| McCall Ronald D | Director | S Sale | 2021-08-25 | 2021-08-26 | 5,667 | $25.63 | $145.2K | 121,768 | SEC↗ |
| Maier Dennis B | Vice President, Operations | S Sale | 2021-08-23 | 2021-08-24 | 2,715 | $25.64 | $69.6K | 17,677 | SEC↗ |
| ACKERMAN THOMAS F | Director | A Award | 2021-06-01 | 2021-06-02 | 4,423 | $29.39 | $130.0K | 119,695 | SEC↗ |
| BEVEVINO DANIEL J | Director | A Award | 2021-06-01 | 2021-06-02 | 4,423 | $29.39 | $130.0K | 119,860 | SEC↗ |
| Borgstrom Marna P | Director | A Award | 2021-06-01 | 2021-06-02 | 4,423 | $29.39 | $130.0K | 18,887 | SEC↗ |
| Bullock James | Director | A Award | 2021-06-01 | 2021-06-02 | 4,423 | $29.39 | $130.0K | 38,446 | SEC↗ |
| Burbank Jeffrey H | Director | A Award | 2021-06-01 | 2021-06-02 | 4,423 | $29.39 | $130.0K | 23,595 | SEC↗ |
| McCall Ronald D | Director | A Award | 2021-06-01 | 2021-06-02 | 4,423 | $29.39 | $130.0K | 127,435 | SEC↗ |
| MORGAN HARVEY | Director | A Award | 2021-06-01 | 2021-06-02 | 4,423 | $29.39 | $130.0K | 54,413 | SEC↗ |
| Salveson Jon W | Director | A Award | 2021-06-01 | 2021-06-02 | 4,423 | $29.39 | $130.0K | 99,639 | SEC↗ |
| Davis John E | Senior VP, Global Sales | M Exercise deriv | 2021-05-25 | 2021-05-27 | 5,402 | $26.24 | $141.7K | 0 | SEC↗ |
| McCall Ronald D | Director | S Sale | 2021-05-25 | 2021-05-27 | 5,783 | $29.55 | $170.9K | 123,012 | SEC↗ |
| Davis John E | Senior VP, Global Sales | S Sale | 2021-05-25 | 2021-05-27 | 6,457 | $29.65 | $191.5K | 71,899 | SEC↗ |
| Davis John E | Senior VP, Global Sales | S Sale | 2021-05-25 | 2021-05-27 | 5,402 | $29.67 | $160.3K | 79,236 | SEC↗ |
| Davis John E | Senior VP, Global Sales | S Sale | 2021-05-25 | 2021-05-27 | 880 | $29.70 | $26.1K | 78,356 | SEC↗ |
| Davis John E | Senior VP, Global Sales | M Exercise | 2021-05-25 | 2021-05-27 | 5,402 | $26.24 | $141.7K | 84,638 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | M Exercise deriv | 2021-05-06 | 2021-05-10 | 6,618 | $10.24 | $67.8K | 0 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | M Exercise deriv | 2021-05-06 | 2021-05-10 | 5,731 | $11.00 | $63.0K | 0 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2021-05-06 | 2021-05-10 | 6,618 | $30.50 | $201.8K | 87,230 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | M Exercise | 2021-05-06 | 2021-05-10 | 6,618 | $10.24 | $67.8K | 93,848 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | M Exercise | 2021-05-06 | 2021-05-10 | 5,731 | $11.00 | $63.0K | 95,013 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2021-05-06 | 2021-05-10 | 5,731 | $30.00 | $171.9K | 89,282 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | M Exercise deriv | 2021-05-05 | 2021-05-07 | 6,618 | $10.24 | $67.8K | 0 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | M Exercise deriv | 2021-05-05 | 2021-05-07 | 5,186 | $11.00 | $57.0K | 0 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | M Exercise deriv | 2021-05-05 | 2021-05-07 | 27,242 | $11.00 | $299.7K | 0 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2021-05-05 | 2021-05-07 | 6,618 | $29.50 | $195.2K | 87,230 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | M Exercise | 2021-05-05 | 2021-05-07 | 6,618 | $10.24 | $67.8K | 93,848 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2021-05-05 | 2021-05-07 | 5,186 | $30.00 | $155.6K | 89,282 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | M Exercise | 2021-05-05 | 2021-05-07 | 5,186 | $11.00 | $57.0K | 94,468 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | S Sale | 2021-05-05 | 2021-05-07 | 27,242 | $30.00 | $817.3K | 292,685 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | M Exercise | 2021-05-05 | 2021-05-07 | 27,242 | $11.00 | $299.7K | 319,927 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | M Exercise deriv | 2021-04-30 | 2021-05-04 | 2,700 | $11.00 | $29.7K | 0 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | M Exercise deriv | 2021-04-30 | 2021-05-04 | 6,800 | $11.00 | $74.8K | 0 | SEC↗ |
| Mackin James P | President & CEO | M Exercise deriv | 2021-04-30 | 2021-05-04 | 16,265 | $10.18 | $165.6K | 0 | SEC↗ |
| Mackin James P | President & CEO | M Exercise deriv | 2021-04-30 | 2021-05-04 | 29,469 | $10.18 | $300.0K | 0 | SEC↗ |
| Maier Dennis B | Vice President, Operations | M Exercise deriv | 2021-04-30 | 2021-05-04 | 3,314 | $21.55 | $71.4K | 0 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2021-04-30 | 2021-05-04 | 2,700 | $30.00 | $81.0K | 89,282 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | M Exercise | 2021-04-30 | 2021-05-04 | 2,700 | $11.00 | $29.7K | 91,982 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | M Exercise | 2021-04-30 | 2021-05-04 | 6,800 | $11.00 | $74.8K | 299,485 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | S Sale | 2021-04-30 | 2021-05-04 | 6,800 | $30.00 | $204.0K | 292,685 | SEC↗ |
| Mackin James P | President & CEO | M Exercise | 2021-04-30 | 2021-05-04 | 29,469 | $10.18 | $300.0K | 333,647 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2021-04-30 | 2021-05-04 | 29,469 | $28.00 | $825.1K | 304,178 | SEC↗ |
| Mackin James P | President & CEO | M Exercise | 2021-04-30 | 2021-05-04 | 16,265 | $10.18 | $165.6K | 320,443 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2021-04-30 | 2021-05-04 | 16,265 | $28.00 | $455.4K | 304,178 | SEC↗ |
| Maier Dennis B | Vice President, Operations | S Sale | 2021-04-30 | 2021-05-04 | 3,314 | $28.00 | $92.8K | 20,392 | SEC↗ |
| Maier Dennis B | Vice President, Operations | M Exercise | 2021-04-30 | 2021-05-04 | 3,314 | $21.55 | $71.4K | 23,706 | SEC↗ |
| Maier Dennis B | Vice President, Operations | S Sale | 2021-04-30 | 2021-05-04 | 547 | $28.00 | $15.3K | 20,392 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | A Award | 2021-03-16 | 2021-03-18 | 8,511 | — | $0 | 9,511 | SEC↗ |
| Capps Scott B | VP, Clinical Research | F Tax w/h | 2021-03-12 | 2021-03-15 | 1,160 | $25.05 | $29.1K | 153,436 | SEC↗ |
| Capps Scott B | VP, Clinical Research | F Tax w/h | 2021-03-12 | 2021-03-15 | 233 | $25.05 | $5.8K | 153,203 | SEC↗ |
| Davis John E | Senior VP, Global Sales | F Tax w/h | 2021-03-12 | 2021-03-15 | 373 | $25.05 | $9.3K | 79,236 | SEC↗ |
| Davis John E | Senior VP, Global Sales | F Tax w/h | 2021-03-12 | 2021-03-15 | 1,863 | $25.05 | $46.7K | 79,609 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | F Tax w/h | 2021-03-12 | 2021-03-15 | 2,235 | $25.05 | $56.0K | 87,677 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | F Tax w/h | 2021-03-12 | 2021-03-15 | 447 | $25.05 | $11.2K | 87,230 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | F Tax w/h | 2021-03-12 | 2021-03-15 | 291 | $25.05 | $7.3K | 89,282 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | F Tax w/h | 2021-03-12 | 2021-03-15 | 1,448 | $25.05 | $36.3K | 89,573 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | F Tax w/h | 2021-03-12 | 2021-03-15 | 2,561 | $25.05 | $64.2K | 293,198 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | F Tax w/h | 2021-03-12 | 2021-03-15 | 513 | $25.05 | $12.9K | 292,685 | SEC↗ |
| Mackin James P | President & CEO | F Tax w/h | 2021-03-12 | 2021-03-15 | 13,092 | $25.05 | $328.0K | 306,852 | SEC↗ |
| Mackin James P | President & CEO | F Tax w/h | 2021-03-12 | 2021-03-15 | 2,674 | $25.05 | $67.0K | 304,178 | SEC↗ |
| Maier Dennis B | Vice President, Operations | F Tax w/h | 2021-03-12 | 2021-03-15 | 233 | $25.05 | $5.8K | 20,939 | SEC↗ |
| Maier Dennis B | Vice President, Operations | F Tax w/h | 2021-03-12 | 2021-03-15 | 1,152 | $25.05 | $28.9K | 21,172 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2021-03-10 | 2021-03-11 | 1,693 | $25.28 | $42.8K | 89,912 | SEC↗ |
| Barthold Franz Peter | VP, Research & Development | F Tax w/h | 2021-03-08 | 2021-03-10 | 76 | $24.30 | $1.8K | 12,121 | SEC↗ |
| Barthold Franz Peter | VP, Research & Development | F Tax w/h | 2021-03-05 | 2021-03-10 | 103 | $24.44 | $2.5K | 12,197 | SEC↗ |
| Capps Scott B | VP, Clinical Research | F Tax w/h | 2021-03-05 | 2021-03-10 | 205 | $24.44 | $5.0K | 154,596 | SEC↗ |
| Davis John E | Senior VP, Global Sales | F Tax w/h | 2021-03-05 | 2021-03-10 | 315 | $24.44 | $7.7K | 81,472 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | F Tax w/h | 2021-03-05 | 2021-03-10 | 299 | $24.44 | $7.3K | 91,605 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | F Tax w/h | 2021-03-05 | 2021-03-10 | 226 | $24.44 | $5.5K | 91,021 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | F Tax w/h | 2021-03-05 | 2021-03-10 | 359 | $24.44 | $8.8K | 295,759 | SEC↗ |
| Mackin James P | President & CEO | F Tax w/h | 2021-03-05 | 2021-03-10 | 1,487 | $24.44 | $36.3K | 319,944 | SEC↗ |
| Maier Dennis B | Vice President, Operations | F Tax w/h | 2021-03-05 | 2021-03-10 | 205 | $24.44 | $5.0K | 22,324 | SEC↗ |
| Simpson Michael S | SVP, Regulatory Affairs and | F Tax w/h | 2021-03-05 | 2021-03-10 | 304 | $24.44 | $7.4K | 33,698 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2021-03-01 | 2021-03-02 | 13,619 | $25.53 | $347.7K | 91,247 | SEC↗ |
| Barthold Franz Peter | VP, Research & Development | A Award | 2021-02-23 | 2021-02-25 | 3,176 | — | $0 | 13,004 | SEC↗ |
| Barthold Franz Peter | VP, Research & Development | F Tax w/h | 2021-02-23 | 2021-02-25 | 704 | $25.41 | $17.9K | 12,300 | SEC↗ |
| Capps Scott B | VP, Clinical Research | F Tax w/h | 2021-02-23 | 2021-02-25 | 563 | $25.41 | $14.3K | 154,801 | SEC↗ |
| Capps Scott B | VP, Clinical Research | A Award | 2021-02-23 | 2021-02-25 | 3,176 | — | $0 | 155,364 | SEC↗ |
| Davis John E | Senior VP, Global Sales | F Tax w/h | 2021-02-23 | 2021-02-25 | 945 | $25.41 | $24.0K | 81,787 | SEC↗ |
| Davis John E | Senior VP, Global Sales | A Award | 2021-02-23 | 2021-02-25 | 5,335 | — | $0 | 82,732 | SEC↗ |
| Getz Matthew A | VP, Human Resources | F Tax w/h | 2021-02-23 | 2021-02-25 | 563 | $25.41 | $14.3K | 9,514 | SEC↗ |
| Getz Matthew A | VP, Human Resources | A Award | 2021-02-23 | 2021-02-25 | 3,176 | — | $0 | 10,077 | SEC↗ |
| Holloway Jean F | VP, General Counsel | F Tax w/h | 2021-02-23 | 2021-02-25 | 990 | $25.41 | $25.2K | 91,904 | SEC↗ |
| Holloway Jean F | VP, General Counsel | A Award | 2021-02-23 | 2021-02-25 | 5,589 | — | $0 | 92,894 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | A Award | 2021-02-23 | 2021-02-25 | 3,493 | — | $0 | 105,485 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | F Tax w/h | 2021-02-23 | 2021-02-25 | 619 | $25.41 | $15.7K | 104,866 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | F Tax w/h | 2021-02-23 | 2021-02-25 | 1,237 | $25.41 | $31.4K | 296,118 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | A Award | 2021-02-23 | 2021-02-25 | 6,987 | — | $0 | 297,355 | SEC↗ |
| Mackin James P | President & CEO | A Award | 2021-02-23 | 2021-02-25 | 28,415 | — | $0 | 325,814 | SEC↗ |
| Mackin James P | President & CEO | F Tax w/h | 2021-02-23 | 2021-02-25 | 4,383 | $25.41 | $111.4K | 321,431 | SEC↗ |
| Maier Dennis B | Vice President, Operations | A Award | 2021-02-23 | 2021-02-25 | 3,176 | — | $0 | 23,092 | SEC↗ |
| Maier Dennis B | Vice President, Operations | F Tax w/h | 2021-02-23 | 2021-02-25 | 563 | $25.41 | $14.3K | 22,529 | SEC↗ |
| Simpson Michael S | SVP, Regulatory Affairs and | F Tax w/h | 2021-02-23 | 2021-02-25 | 900 | $25.41 | $22.9K | 34,002 | SEC↗ |
| Simpson Michael S | SVP, Regulatory Affairs and | A Award | 2021-02-23 | 2021-02-25 | 5,081 | — | $0 | 34,902 | SEC↗ |
| Barthold Franz Peter | VP, Research & Development | A Award deriv | 2021-02-17 | 2021-02-19 | 10,016 | — | $0 | 10,016 | SEC↗ |
| Capps Scott B | VP, Clinical Research | A Award deriv | 2021-02-17 | 2021-02-19 | 10,016 | — | $0 | 10,016 | SEC↗ |
| Davis John E | Senior VP, Global Sales | A Award deriv | 2021-02-17 | 2021-02-19 | 17,008 | — | $0 | 17,008 | SEC↗ |
| Getz Matthew A | VP, Human Resources | A Award deriv | 2021-02-17 | 2021-02-19 | 10,516 | — | $0 | 10,516 | SEC↗ |
| Holloway Jean F | VP, General Counsel | A Award deriv | 2021-02-17 | 2021-02-19 | 19,247 | — | $0 | 19,247 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | A Award deriv | 2021-02-17 | 2021-02-19 | 10,516 | — | $0 | 10,516 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | A Award deriv | 2021-02-17 | 2021-02-19 | 22,025 | — | $0 | 22,025 | SEC↗ |
| Mackin James P | President & CEO | A Award deriv | 2021-02-17 | 2021-02-19 | 93,519 | — | $0 | 93,519 | SEC↗ |
| Maier Dennis B | Vice President, Operations | M Exercise deriv | 2021-02-17 | 2021-02-19 | 6,630 | $21.55 | $142.9K | 0 | SEC↗ |
| Maier Dennis B | Vice President, Operations | A Award deriv | 2021-02-17 | 2021-02-19 | 11,017 | — | $0 | 11,017 | SEC↗ |
| Simpson Michael S | SVP, Regulatory Affairs and | A Award deriv | 2021-02-17 | 2021-02-19 | 15,118 | — | $0 | 15,118 | SEC↗ |
| Barthold Franz Peter | VP, Research & Development | A Award | 2021-02-17 | 2021-02-19 | 3,548 | — | $0 | 9,828 | SEC↗ |
| Capps Scott B | VP, Clinical Research | A Award | 2021-02-17 | 2021-02-19 | 3,548 | — | $0 | 152,188 | SEC↗ |
| Davis John E | Senior VP, Global Sales | A Award | 2021-02-17 | 2021-02-19 | 6,024 | — | $0 | 77,397 | SEC↗ |
| Getz Matthew A | VP, Human Resources | A Award | 2021-02-17 | 2021-02-19 | 3,725 | — | $0 | 6,901 | SEC↗ |
| Holloway Jean F | VP, General Counsel | A Award | 2021-02-17 | 2021-02-19 | 6,817 | — | $0 | 87,305 | SEC↗ |
| Holloway Jean F | VP, General Counsel | A Award | 2021-02-17 | 2021-02-19 | 14,485 | — | $0 | 80,488 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | A Award | 2021-02-17 | 2021-02-19 | 3,725 | — | $0 | 101,992 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | A Award | 2021-02-17 | 2021-02-19 | 7,801 | — | $0 | 290,368 | SEC↗ |
| Mackin James P | President & CEO | A Award | 2021-02-17 | 2021-02-19 | 33,125 | — | $0 | 297,399 | SEC↗ |
| Maier Dennis B | Vice President, Operations | A Award | 2021-02-17 | 2021-02-19 | 3,902 | — | $0 | 19,916 | SEC↗ |
| Maier Dennis B | Vice President, Operations | S Sale | 2021-02-17 | 2021-02-19 | 6,630 | $24.73 | $164.0K | 16,581 | SEC↗ |
| Maier Dennis B | Vice President, Operations | S Sale | 2021-02-17 | 2021-02-19 | 567 | $24.64 | $14.0K | 16,014 | SEC↗ |
| Maier Dennis B | Vice President, Operations | M Exercise | 2021-02-17 | 2021-02-19 | 6,630 | $21.55 | $142.9K | 23,211 | SEC↗ |
| Simpson Michael S | SVP, Regulatory Affairs and | A Award | 2021-02-17 | 2021-02-19 | 5,355 | — | $0 | 29,821 | SEC↗ |
| Capps Scott B | VP, Clinical Research | M Exercise deriv | 2020-12-15 | 2020-12-16 | 10,000 | $9.97 | $99.7K | 0 | SEC↗ |
| MORGAN HARVEY | Director | G Gift | 2020-12-15 | 2020-12-16 | 2,080 | — | $0 | 49,990 | SEC↗ |
| MORGAN HARVEY | Director | G Gift | 2020-12-15 | 2020-12-16 | 2,080 | — | $0 | 42,697 | SEC↗ |
| Capps Scott B | VP, Clinical Research | M Exercise | 2020-12-15 | 2020-12-16 | 10,000 | $9.97 | $99.7K | 157,006 | SEC↗ |
| Capps Scott B | VP, Clinical Research | S Sale | 2020-12-15 | 2020-12-16 | 8,366 | $21.34 | $178.5K | 148,640 | SEC↗ |
| Maier Dennis B | Vice President, Operations | S Sale | 2020-12-14 | 2020-12-15 | 1,843 | $21.85 | $40.3K | 16,240 | SEC↗ |
| McCall Ronald D | Director | S Sale | 2020-12-14 | 2020-12-15 | 4,638 | $21.79 | $101.1K | 128,795 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | G Gift | 2020-12-14 | 2020-12-16 | 1,375 | $21.25 | $29.2K | 98,267 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | M Exercise | 2020-12-14 | 2020-12-16 | 6,666 | $9.97 | $66.5K | 99,642 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | M Exercise deriv | 2020-12-10 | 2020-12-14 | 16,666 | $9.97 | $166.2K | 0 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | S Sale | 2020-12-10 | 2020-12-14 | 16,666 | $23.00 | $383.3K | 282,567 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | M Exercise | 2020-12-10 | 2020-12-14 | 16,666 | $9.97 | $166.2K | 299,233 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | M Exercise deriv | 2020-12-01 | 2020-12-02 | 6,666 | $9.97 | $66.5K | 0 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2020-12-01 | 2020-12-02 | 6,666 | $20.78 | $138.5K | 92,976 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | M Exercise | 2020-12-01 | 2020-12-02 | 6,666 | $9.97 | $66.5K | 99,642 | SEC↗ |
| Barthold Franz Peter | VP, Research & Development | F Tax w/h | 2020-12-01 | 2020-12-03 | 654 | $20.93 | $13.7K | 6,280 | SEC↗ |
| Maier Dennis B | Vice President, Operations | F Tax w/h | 2020-11-02 | 2020-11-04 | 1,585 | $17.62 | $27.9K | 18,083 | SEC↗ |
| Mackin James P | President & CEO | P Buy | 2020-09-16 | 2020-10-01 | 7,500 | $16.74 | $125.5K | 264,274 | SEC↗ |
| Mackin James P | President & CEO | A Award | 2020-09-16 | 2020-09-16 | 7,500 | $16.74 | $125.5K | 264,274 | SEC↗ |
| Bullock James | Director | P Buy | 2020-09-16 | 2020-09-17 | 10,000 | $16.63 | $166.3K | 34,023 | SEC↗ |
| Davis John E | Senior VP, Global Sales | P Buy | 2020-09-16 | 2020-09-17 | 10,000 | $16.65 | $166.5K | 70,451 | SEC↗ |
| ACKERMAN THOMAS F | Director | A Award | 2020-06-01 | 2020-06-02 | 5,667 | $22.94 | $130.0K | 115,272 | SEC↗ |
| BEVEVINO DANIEL J | Director | A Award | 2020-06-01 | 2020-06-02 | 5,667 | $22.94 | $130.0K | 115,437 | SEC↗ |
| Borgstrom Marna P | Director | A Award | 2020-06-01 | 2020-06-02 | 5,667 | $22.94 | $130.0K | 14,464 | SEC↗ |
| Bullock James | Director | A Award | 2020-06-01 | 2020-06-02 | 5,667 | $22.94 | $130.0K | 24,023 | SEC↗ |
| Burbank Jeffrey H | Director | A Award | 2020-06-01 | 2020-06-02 | 5,667 | $22.94 | $130.0K | 19,172 | SEC↗ |
| McCall Ronald D | Director | A Award | 2020-06-01 | 2020-06-02 | 5,667 | $22.94 | $130.0K | 133,433 | SEC↗ |
| MORGAN HARVEY | Director | A Award | 2020-06-01 | 2020-06-02 | 5,667 | $22.94 | $130.0K | 52,070 | SEC↗ |
| Salveson Jon W | Director | A Award | 2020-06-01 | 2020-06-02 | 5,667 | $22.94 | $130.0K | 95,216 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2020-05-28 | 2020-05-29 | 3,000 | $23.81 | $71.4K | 99,642 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | G Gift | 2020-05-22 | 2020-05-27 | 125 | $22.86 | $2.9K | 282,567 | SEC↗ |
| Bogenschuetz Thomas J | VP, EMEA & General Manager | A Award deriv | 2020-05-05 | 2020-05-07 | 877 | — | $0 | 23,451 | SEC↗ |
| Capps Scott B | VP, Clinical Research | A Award deriv | 2020-05-05 | 2020-05-07 | 1,797 | — | $0 | 147,006 | SEC↗ |
| Davis John E | Senior VP, Global Sales | A Award deriv | 2020-05-05 | 2020-05-07 | 1,941 | — | $0 | 60,451 | SEC↗ |
| Getz Matthew A | VP, Human Resources | A Award deriv | 2020-05-05 | 2020-05-07 | 1,396 | — | $0 | 3,176 | SEC↗ |
| Holloway Jean F | VP, General Counsel | A Award deriv | 2020-05-05 | 2020-05-07 | 2,011 | — | $0 | 65,051 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | A Award deriv | 2020-05-05 | 2020-05-07 | 1,611 | — | $0 | 102,642 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | A Award deriv | 2020-05-05 | 2020-05-07 | 2,421 | — | $0 | 282,692 | SEC↗ |
| Mackin James P | President & CEO | A Award deriv | 2020-05-05 | 2020-05-07 | 3,832 | — | $0 | 256,774 | SEC↗ |
| Maier Dennis B | Vice President, Operations | A Award deriv | 2020-05-05 | 2020-05-07 | 1,526 | — | $0 | 19,668 | SEC↗ |
| Simpson Michael S | SVP, Regulatory Affairs and | A Award deriv | 2020-05-05 | 2020-05-07 | 1,871 | — | $0 | 24,387 | SEC↗ |
| ACKERMAN THOMAS F | Director | A Award | 2020-05-05 | 2020-05-06 | 1,455 | — | $0 | 109,605 | SEC↗ |
| BEVEVINO DANIEL J | Director | A Award | 2020-05-05 | 2020-05-06 | 1,620 | — | $0 | 109,770 | SEC↗ |
| Borgstrom Marna P | Director | A Award | 2020-05-05 | 2020-05-06 | 1,178 | — | $0 | 8,797 | SEC↗ |
| Bullock James | Director | A Award | 2020-05-05 | 2020-05-06 | 1,289 | — | $0 | 18,356 | SEC↗ |
| Burbank Jeffrey H | Director | A Award | 2020-05-05 | 2020-05-06 | 1,178 | — | $0 | 13,505 | SEC↗ |
| McCall Ronald D | Director | A Award | 2020-05-05 | 2020-05-06 | 1,620 | — | $0 | 129,485 | SEC↗ |
| MORGAN HARVEY | Director | A Award | 2020-05-05 | 2020-05-06 | 1,620 | — | $0 | 46,403 | SEC↗ |
| Salveson Jon W | Director | A Award | 2020-05-05 | 2020-05-06 | 1,399 | — | $0 | 89,549 | SEC↗ |
| McCall Ronald D | Director | S Sale | 2020-05-05 | 2020-05-07 | 1,719 | $22.82 | $39.2K | 127,766 | SEC↗ |
| Bogenschuetz Thomas J | VP, EMEA & General Manager | F Tax w/h | 2020-03-12 | 2020-03-16 | 337 | $20.24 | $6.8K | 23,451 | SEC↗ |
| Capps Scott B | VP, Clinical Research | F Tax w/h | 2020-03-12 | 2020-03-16 | 233 | $20.24 | $4.7K | 147,006 | SEC↗ |
| Capps Scott B | VP, Clinical Research | A Award | 2020-03-12 | 2020-03-16 | 1,998 | — | $0 | 147,239 | SEC↗ |
| Davis John E | Senior VP, Global Sales | F Tax w/h | 2020-03-12 | 2020-03-16 | 373 | $20.24 | $7.5K | 60,451 | SEC↗ |
| Davis John E | Senior VP, Global Sales | A Award | 2020-03-12 | 2020-03-16 | 3,248 | — | $0 | 60,824 | SEC↗ |
| Holloway Jean F | VP, General Counsel | A Award | 2020-03-12 | 2020-03-16 | 3,390 | — | $0 | 65,498 | SEC↗ |
| Holloway Jean F | VP, General Counsel | F Tax w/h | 2020-03-12 | 2020-03-16 | 447 | $20.24 | $9.0K | 65,051 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | A Award | 2020-03-12 | 2020-03-16 | 2,300 | — | $0 | 102,934 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | F Tax w/h | 2020-03-12 | 2020-03-16 | 292 | $20.24 | $5.9K | 102,642 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | F Tax w/h | 2020-03-12 | 2020-03-16 | 513 | $20.24 | $10.4K | 282,692 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | A Award | 2020-03-12 | 2020-03-16 | 4,100 | — | $0 | 283,205 | SEC↗ |
| Mackin James P | President & CEO | F Tax w/h | 2020-03-12 | 2020-03-16 | 2,674 | $20.24 | $54.1K | 256,774 | SEC↗ |
| Mackin James P | President & CEO | A Award | 2020-03-12 | 2020-03-16 | 14,000 | — | $0 | 259,448 | SEC↗ |
| Maier Dennis B | Vice President, Operations | F Tax w/h | 2020-03-12 | 2020-03-16 | 226 | $20.24 | $4.6K | 19,668 | SEC↗ |
| Bogenschuetz Thomas J | VP, EMEA & General Manager | F Tax w/h | 2020-03-05 | 2020-03-09 | 911 | $24.93 | $22.7K | 23,788 | SEC↗ |
| Bogenschuetz Thomas J | VP, EMEA & General Manager | A Award | 2020-03-05 | 2020-03-09 | 4,084 | — | $0 | 24,699 | SEC↗ |
| Capps Scott B | VP, Clinical Research | A Award | 2020-03-05 | 2020-03-09 | 2,320 | — | $0 | 149,587 | SEC↗ |
| Capps Scott B | VP, Clinical Research | F Tax w/h | 2020-03-05 | 2020-03-09 | 350 | $24.93 | $8.7K | 149,237 | SEC↗ |
| Davis John E | Senior VP, Global Sales | F Tax w/h | 2020-03-05 | 2020-03-09 | 615 | $24.93 | $15.3K | 64,072 | SEC↗ |
| Davis John E | Senior VP, Global Sales | A Award | 2020-03-05 | 2020-03-09 | 4,084 | — | $0 | 64,687 | SEC↗ |
| Holloway Jean F | VP, General Counsel | A Award | 2020-03-05 | 2020-03-09 | 4,084 | — | $0 | 69,503 | SEC↗ |
| Holloway Jean F | VP, General Counsel | F Tax w/h | 2020-03-05 | 2020-03-09 | 615 | $24.93 | $15.3K | 68,888 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | A Award | 2020-03-05 | 2020-03-09 | 2,554 | — | $0 | 105,619 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | F Tax w/h | 2020-03-05 | 2020-03-09 | 385 | $24.93 | $9.6K | 105,234 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | F Tax w/h | 2020-03-05 | 2020-03-09 | 734 | $24.93 | $18.3K | 287,305 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | A Award | 2020-03-05 | 2020-03-09 | 4,874 | — | $0 | 288,039 | SEC↗ |
| Mackin James P | President & CEO | A Award | 2020-03-05 | 2020-03-09 | 19,756 | — | $0 | 277,903 | SEC↗ |
| Mackin James P | President & CEO | F Tax w/h | 2020-03-05 | 2020-03-09 | 4,455 | $24.93 | $111.1K | 273,448 | SEC↗ |
| Maier Dennis B | Vice President, Operations | A Award | 2020-03-05 | 2020-03-09 | 2,320 | — | $0 | 20,305 | SEC↗ |
| Maier Dennis B | Vice President, Operations | F Tax w/h | 2020-03-05 | 2020-03-09 | 411 | $24.93 | $10.2K | 19,894 | SEC↗ |
| Simpson Michael S | SVP, Regulatory Affairs and | F Tax w/h | 2020-03-05 | 2020-03-09 | 658 | $24.93 | $16.4K | 24,387 | SEC↗ |
| Simpson Michael S | SVP, Regulatory Affairs and | A Award | 2020-03-05 | 2020-03-09 | 3,714 | — | $0 | 25,045 | SEC↗ |
| McCall Ronald D | Director | S Sale | 2020-02-24 | 2020-02-25 | 4,734 | $26.05 | $123.3K | 127,865 | SEC↗ |
| Capps Scott B | VP, Clinical Research | A Award | 2020-02-21 | 2020-02-25 | 1,998 | — | $0 | 147,559 | SEC↗ |
| Capps Scott B | VP, Clinical Research | F Tax w/h | 2020-02-21 | 2020-02-25 | 292 | $26.20 | $7.7K | 147,267 | SEC↗ |
| Capps Scott B | VP, Clinical Research | F Tax w/h | 2020-02-21 | 2020-02-25 | 1,510 | $26.20 | $39.6K | 145,561 | SEC↗ |
| Davis John E | Senior VP, Global Sales | F Tax w/h | 2020-02-21 | 2020-02-25 | 2,328 | $26.20 | $61.0K | 57,844 | SEC↗ |
| Davis John E | Senior VP, Global Sales | A Award | 2020-02-21 | 2020-02-25 | 3,248 | — | $0 | 61,092 | SEC↗ |
| Davis John E | Senior VP, Global Sales | F Tax w/h | 2020-02-21 | 2020-02-25 | 489 | $26.20 | $12.8K | 60,603 | SEC↗ |
| Holloway Jean F | VP, General Counsel | F Tax w/h | 2020-02-21 | 2020-02-25 | 2,269 | $26.20 | $59.4K | 62,540 | SEC↗ |
| Holloway Jean F | VP, General Counsel | A Award | 2020-02-21 | 2020-02-25 | 3,390 | — | $0 | 65,930 | SEC↗ |
| Holloway Jean F | VP, General Counsel | F Tax w/h | 2020-02-21 | 2020-02-25 | 511 | $26.20 | $13.4K | 65,419 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | F Tax w/h | 2020-02-21 | 2020-02-25 | 339 | $26.20 | $8.9K | 103,065 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | A Award | 2020-02-21 | 2020-02-25 | 2,300 | — | $0 | 103,404 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | F Tax w/h | 2020-02-21 | 2020-02-25 | 1,718 | $26.20 | $45.0K | 101,104 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | F Tax w/h | 2020-02-21 | 2020-02-25 | 618 | $26.20 | $16.2K | 283,165 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | A Award | 2020-02-21 | 2020-02-25 | 4,100 | — | $0 | 283,783 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | F Tax w/h | 2020-02-21 | 2020-02-25 | 2,869 | $26.20 | $75.2K | 279,683 | SEC↗ |
| Mackin James P | President & CEO | F Tax w/h | 2020-02-21 | 2020-02-25 | 3,157 | $26.20 | $82.7K | 258,147 | SEC↗ |
| Mackin James P | President & CEO | F Tax w/h | 2020-02-21 | 2020-02-25 | 6,842 | $26.20 | $179.3K | 247,304 | SEC↗ |
| Mackin James P | President & CEO | A Award | 2020-02-21 | 2020-02-25 | 14,000 | — | $0 | 261,304 | SEC↗ |
| Capps Scott B | VP, Clinical Research | A Award deriv | 2020-02-19 | 2020-02-21 | 9,645 | — | $0 | 9,645 | SEC↗ |
| Davis John E | Senior VP, Global Sales | A Award deriv | 2020-02-19 | 2020-02-21 | 16,204 | — | $0 | 16,204 | SEC↗ |
| Getz Matthew A | VP, Human Resources | A Award deriv | 2020-02-19 | 2020-02-21 | 9,645 | — | $0 | 9,645 | SEC↗ |
| Holloway Jean F | VP, General Counsel | A Award deriv | 2020-02-19 | 2020-02-21 | 16,975 | — | $0 | 16,975 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | A Award deriv | 2020-02-19 | 2020-02-21 | 10,610 | — | $0 | 10,610 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | A Award deriv | 2020-02-19 | 2020-02-21 | 21,219 | — | $0 | 21,219 | SEC↗ |
| Mackin James P | President & CEO | A Award deriv | 2020-02-19 | 2020-02-21 | 86,296 | — | $0 | 86,296 | SEC↗ |
| Maier Dennis B | Vice President, Operations | A Award deriv | 2020-02-19 | 2020-02-21 | 9,645 | — | $0 | 9,645 | SEC↗ |
| Simpson Michael S | SVP, Regulatory Affairs and | A Award deriv | 2020-02-19 | 2020-02-21 | 15,432 | — | $0 | 15,432 | SEC↗ |
| Capps Scott B | VP, Clinical Research | A Award | 2020-02-19 | 2020-02-21 | 3,176 | — | $0 | 147,071 | SEC↗ |
| Davis John E | Senior VP, Global Sales | A Award | 2020-02-19 | 2020-02-21 | 5,335 | — | $0 | 60,172 | SEC↗ |
| Getz Matthew A | VP, Human Resources | A Award | 2020-02-19 | 2020-02-21 | 3,176 | — | $0 | 3,176 | SEC↗ |
| Holloway Jean F | VP, General Counsel | A Award | 2020-02-19 | 2020-02-21 | 5,589 | — | $0 | 64,809 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | A Award | 2020-02-19 | 2020-02-21 | 3,493 | — | $0 | 102,822 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | A Award | 2020-02-19 | 2020-02-21 | 6,987 | — | $0 | 282,552 | SEC↗ |
| Mackin James P | President & CEO | A Award | 2020-02-19 | 2020-02-21 | 28,415 | — | $0 | 254,146 | SEC↗ |
| Maier Dennis B | Vice President, Operations | A Award | 2020-02-19 | 2020-02-21 | 3,176 | — | $0 | 17,985 | SEC↗ |
| Simpson Michael S | SVP, Regulatory Affairs and | A Award | 2020-02-19 | 2020-02-21 | 5,081 | — | $0 | 21,331 | SEC↗ |
| Holloway Jean F | VP, General Counsel | M Exercise deriv | 2020-01-21 | 2020-01-23 | 8,458 | $9.64 | $81.5K | 0 | SEC↗ |
| Holloway Jean F | VP, General Counsel | S Sale | 2020-01-21 | 2020-01-23 | 8,458 | $30.00 | $253.7K | 58,864 | SEC↗ |
| Holloway Jean F | VP, General Counsel | M Exercise | 2020-01-21 | 2020-01-23 | 8,458 | $9.64 | $81.5K | 67,322 | SEC↗ |
| Holloway Jean F | VP, General Counsel | M Exercise deriv | 2020-01-16 | 2020-01-21 | 195 | $9.64 | $1.9K | 0 | SEC↗ |
| Holloway Jean F | VP, General Counsel | M Exercise | 2020-01-16 | 2020-01-21 | 195 | $9.64 | $1.9K | 59,059 | SEC↗ |
| Holloway Jean F | VP, General Counsel | S Sale | 2020-01-16 | 2020-01-21 | 195 | $30.00 | $5.8K | 58,864 | SEC↗ |
| Holloway Jean F | VP, General Counsel | M Exercise deriv | 2019-12-12 | 2019-12-13 | 3,000 | $10.24 | $30.7K | 13,236 | SEC↗ |
| Holloway Jean F | VP, General Counsel | M Exercise | 2019-12-12 | 2019-12-13 | 3,000 | $10.24 | $30.7K | 61,864 | SEC↗ |
| Holloway Jean F | VP, General Counsel | S Sale | 2019-12-12 | 2019-12-13 | 3,000 | $26.00 | $78.0K | 58,864 | SEC↗ |
| Capps Scott B | VP, Clinical Research | M Exercise deriv | 2019-11-26 | 2019-11-27 | 10,000 | $6.12 | $61.2K | 0 | SEC↗ |
| Capps Scott B | VP, Clinical Research | M Exercise | 2019-11-26 | 2019-11-27 | 10,000 | $6.12 | $61.2K | 151,079 | SEC↗ |
| Capps Scott B | VP, Clinical Research | S Sale | 2019-11-26 | 2019-11-27 | 7,184 | $24.93 | $179.1K | 143,895 | SEC↗ |
| McCall Ronald D | Director | S Sale | 2019-11-19 | 2019-11-19 | 4,000 | $24.64 | $98.6K | 132,599 | SEC↗ |
| Mackin James P | President & CEO | P Buy | 2019-11-13 | 2019-11-13 | 5,000 | $23.47 | $117.3K | 225,731 | SEC↗ |
| MORGAN HARVEY | Director | G Gift | 2019-11-06 | 2019-11-07 | 2,319 | $23.06 | $53.5K | 44,783 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | G Gift | 2019-06-05 | 2019-06-06 | 1,000 | $29.17 | $29.2K | 99,329 | SEC↗ |
| Capps Scott B | VP, Clinical Research | S Sale | 2019-05-31 | 2019-06-03 | 2,000 | $28.55 | $57.1K | 141,079 | SEC↗ |
| McCall Ronald D | Director | S Sale | 2019-05-24 | 2019-05-29 | 1,563 | $28.47 | $44.5K | 136,599 | SEC↗ |
| McCall Ronald D | Director | S Sale | 2019-05-23 | 2019-05-24 | 1,000 | $28.00 | $28.0K | 138,162 | SEC↗ |
| McCall Ronald D | Director | S Sale | 2019-05-22 | 2019-05-24 | 2,700 | $29.02 | $78.4K | 139,162 | SEC↗ |
| ACKERMAN THOMAS F | Director | A Award | 2019-05-16 | 2019-05-17 | 4,163 | — | $0 | 108,150 | SEC↗ |
| BEVEVINO DANIEL J | Director | A Award | 2019-05-16 | 2019-05-17 | 4,163 | — | $0 | 108,150 | SEC↗ |
| Borgstrom Marna P | Director | A Award | 2019-05-16 | 2019-05-17 | 4,163 | — | $0 | 7,619 | SEC↗ |
| Bullock James | Director | A Award | 2019-05-16 | 2019-05-17 | 4,163 | — | $0 | 17,067 | SEC↗ |
| Burbank Jeffrey H | Director | A Award | 2019-05-16 | 2019-05-17 | 4,163 | — | $0 | 12,327 | SEC↗ |
| McCall Ronald D | Director | A Award | 2019-05-16 | 2019-05-17 | 4,163 | — | $0 | 141,862 | SEC↗ |
| MORGAN HARVEY | Director | A Award | 2019-05-16 | 2019-05-17 | 4,163 | — | $0 | 47,102 | SEC↗ |
| Salveson Jon W | Director | A Award | 2019-05-16 | 2019-05-17 | 4,163 | — | $0 | 88,150 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | G Gift | 2019-05-13 | 2019-05-14 | 90 | $29.88 | $2.7K | 275,565 | SEC↗ |
| Holloway Jean F | VP, General Counsel | M Exercise deriv | 2019-05-06 | 2019-05-07 | 8,654 | $9.64 | $83.4K | 8,653 | SEC↗ |
| Holloway Jean F | VP, General Counsel | S Sale | 2019-05-06 | 2019-05-07 | 8,654 | $32.00 | $276.9K | 58,366 | SEC↗ |
| Holloway Jean F | VP, General Counsel | M Exercise | 2019-05-06 | 2019-05-07 | 8,654 | $9.64 | $83.4K | 67,020 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | M Exercise deriv | 2019-05-03 | 2019-05-07 | 16,666 | $6.12 | $102.0K | 0 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | M Exercise | 2019-05-03 | 2019-05-07 | 16,666 | $6.12 | $102.0K | 300,910 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | S Sale | 2019-05-03 | 2019-05-07 | 8,589 | $31.38 | $269.5K | 275,655 | SEC↗ |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | S Sale | 2019-05-03 | 2019-05-07 | 16,666 | $31.35 | $522.5K | 284,244 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2019-05-03 | 2019-05-07 | 50,000 | $31.31 | $1.57M | 220,731 | SEC↗ |
| Holloway Jean F | VP, General Counsel | M Exercise deriv | 2019-05-01 | 2019-05-03 | 10,000 | $10.24 | $102.4K | 16,236 | SEC↗ |
| Holloway Jean F | VP, General Counsel | S Sale | 2019-05-01 | 2019-05-03 | 10,000 | $31.50 | $315.0K | 58,366 | SEC↗ |
| Holloway Jean F | VP, General Counsel | M Exercise | 2019-05-01 | 2019-05-03 | 10,000 | $10.24 | $102.4K | 68,366 | SEC↗ |
| Bogenschuetz Thomas J | VP, EMEA & General Manager | A Award | 2019-03-14 | 2019-03-18 | 3,092 | — | $0 | 21,350 | SEC↗ |
| Bogenschuetz Thomas J | VP, EMEA & General Manager | F Tax w/h | 2019-03-14 | 2019-03-18 | 735 | $28.92 | $21.3K | 20,615 | SEC↗ |
| Capps Scott B | VP, Clinical Research | A Award | 2019-03-14 | 2019-03-18 | 3,092 | — | $0 | 143,545 | SEC↗ |
| Capps Scott B | VP, Clinical Research | F Tax w/h | 2019-03-14 | 2019-03-18 | 2 | $29.70 | $59 | 140,453 | SEC↗ |
| Capps Scott B | VP, Clinical Research | F Tax w/h | 2019-03-14 | 2019-03-18 | 466 | $28.92 | $13.5K | 143,079 | SEC↗ |
| Davis John E | Senior VP, Global Sales | F Tax w/h | 2019-03-14 | 2019-03-18 | 3 | $29.70 | $89 | 49,754 | SEC↗ |
| Davis John E | Senior VP, Global Sales | A Award | 2019-03-14 | 2019-03-18 | 4,948 | — | $0 | 54,702 | SEC↗ |
| Davis John E | Senior VP, Global Sales | F Tax w/h | 2019-03-14 | 2019-03-18 | 745 | $28.92 | $21.5K | 53,957 | SEC↗ |
| Holloway Jean F | VP, General Counsel | A Award | 2019-03-14 | 2019-03-18 | 5,940 | — | $0 | 59,260 | SEC↗ |
| Holloway Jean F | VP, General Counsel | F Tax w/h | 2019-03-14 | 2019-03-18 | 3 | $29.70 | $89 | 53,320 | SEC↗ |
| Holloway Jean F | VP, General Counsel | F Tax w/h | 2019-03-14 | 2019-03-18 | 894 | $28.92 | $25.9K | 58,366 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | A Award | 2019-03-14 | 2019-03-18 | 3,866 | — | $0 | 100,911 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | F Tax w/h | 2019-03-14 | 2019-03-18 | 2 | $29.70 | $59 | 97,045 | SEC↗ |